Suchergebnisse - "Mu, Guangyan"

PubPharm (13)

1

The Pharmacogenetic Variability Associated With the Pharmacokinetics and Pharmacodynamics of Rivaroxaban in Healthy Chinese Subjects : A National Multicenter Exploratory Study

enthalten in: Clinical therapeutics | 2024

von Liu, Z. | Xie, Q. | Zhao, X. | +14

2

Genetic variants influenced the risk of bleeding and pharmacodynamics of rivaroxaban in patients with nonvalvular atrial fibrillation : A multicentre prospective cohort study

enthalten in: Clinical and translational medicine | 2023

von Xiang, Q. | Wang, Z. | Mu, G. | +18

3

Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic-pharmacodynamic profiles of rivaroxaban

enthalten in: Human genomics | 2022

von Zhang, H. | Zhang, Z. | Liu, Z. | +10

4

Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic–pharmacodynamic profiles of rivaroxaban

enthalten in: Human genomics | 2022

von Zhang, H. | Zhang, Z. | Liu, Z. | +10

5

Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic–pharmacodynamic profiles of rivaroxaban

enthalten in: Human genomics | 2022

von Zhang, H. | Zhang, Z. | Liu, Z. | +10

6

Standard- vs. low-dose rivaroxaban in patients with atrial fibrillation : a systematic review and meta-analysis

enthalten in: European journal of clinical pharmacology | 2022

von Mu, G. | Zhang, H. | Liu, Z. | +9

7

Comparison of non-vitamin K antagonist oral anticoagulants on bleeding and thrombosis

enthalten in: Journal of clinical pharmacy and therapeutics | 2021

von Liu, Z. | Ma, L. | Zhang, H. | +10

8

Target Drug-Calibrated Anti-Xa Activity Assays and Expected Peak-Trough Levels in an Asian Population : A Multicenter Study

enthalten in: American journal of cardiovascular drugs : drugs, devices, and other interventions | 2021

von Liu, Z. | Xie, Q. | Zhang, H. | +6

9

Standard- vs. low-dose rivaroxaban in patients with atrial fibrillation: a systematic review and meta-analysis

enthalten in: European journal of clinical pharmacology | 2021

von Mu, G. | Zhang, H. | Liu, Z. | +9

10

Standard- vs. low-dose rivaroxaban in patients with atrial fibrillation: a systematic review and meta-analysis

enthalten in: European journal of clinical pharmacology | 2021

von Mu, G. | Zhang, H. | Liu, Z. | +9